Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy
Top Cited Papers
- 12 October 2005
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 46 (8), 1411-1416
- https://doi.org/10.1016/j.jacc.2005.04.064
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary SyndromesJAMA, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesJournal of the American College of Cardiology, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trialThe Lancet, 2002
- Approach to lipoprotein management in 2001 National Cholesterol GuidelinesThe American Journal of Cardiology, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- United states cholesterol guidelines 2001: expanded scope of intensive low-density lipoprotein–lowering therapyThe American Journal of Cardiology, 2001
- Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled TrialJAMA, 2001
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)Circulation, 1998